Log in to save to my catalogue

Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge

Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e4b054b28cfc4c97a2cc7fdc9d39a92a

Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge

About this item

Full title

Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2020-12, Vol.25 (23), p.5695

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

The RNA-dependent RNA polymerase (RdRp) is an essential enzyme for the viral replication process, catalyzing the viral RNA synthesis using a metal ion-dependent mechanism. In recent years, RdRp has emerged as an optimal target for the development of antiviral drugs, as demonstrated by recent approvals of sofosbuvir and remdesivir against Hepatitis...

Alternative Titles

Full title

Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e4b054b28cfc4c97a2cc7fdc9d39a92a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e4b054b28cfc4c97a2cc7fdc9d39a92a

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules25235695

How to access this item